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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S258Correlation coefﬁcients > 0.50 or < -0.50 were interpreted as strong
associations.
Results:Ouranalyses includeddata from37patientswith an average age
of 61.7 (SD ¼ 10.6) years and body mass index of 33.0 (SD ¼ 7.7) kg/m2.
The samplewas 68% female and 86% had a Kellgren/Lawrence grade 2.
All correlations were in the hypothesized direction and can be viewed in
Table 1. Mindfulness scores demonstrated strong inverse correlations
with psychological symptoms as measured by the BDI-II and the PSS. In
contrast, mindfulness scores had moderate-strong positive correlations
with quality of life as measured by the SF-36 Mental Component
Summary and Physical Component Summary. A moderate to strong
positive correlation was also seen between mindfulness scores and the
CPSS. We found no signiﬁcant correlations between mindfulness scores
and measures of pain and function.
Conclusions: Our results suggest that mindfulness is associated with
psychological symptoms, self-efﬁcacy, and quality of life among
patients with symptomatic KOA. As patients reported higher levels of
mindfulness they tended to report less depression and stress as well as
greater self efﬁcacy and quality of life. Future studies should evaluate
the efﬁcacy of mind-body therapies aimed at increasing mindfulness in
this patient population.Table 1
Descriptive Statistics and Spearman Correlation Coefﬁcients
Measure Mean (SD) Correlation with
Mindfulness Scores (r)
P-Value
FFMQ (39-195)* 138.41 (15.36) 1.00 -
WOMAC Pain (0-500) 257.14 (99.85) -0.05 0.78
WOMAC Function
(0-1700)
898.28 (356.40) -0.02 0.91
6-Minute Walk Test
(meters)*
403.84 (81.10) 0.19 0.29
20-Meter Walk Test
(minutes)
18.12 (3.55) -0.19 0.27
BDI-II (0-63) 8.61 (10.49) -0.58 <0.0001
PSS (0-40) 13.11 (7.06) -0.57 <0.0001
CPSS (1-10)* 6.33 (2.12) 0.44 0.007
SF-36 MCS (0-100)* 52.05 (9.94) 0.64 <0.0001
SF-36 PCS (0-100)* 37.88 (7.92) 0.44 0.007
FFMQ¼Five Facet Mindfulness Questionnaire; WOMAC¼Western Ontario and
McMaster Universities Arthritis Index; CPSS¼Chronic Pain Self Efﬁcacy Scale;
PSS¼Perceived Stress Scale; SF-36MCS and PCS¼Medical Outcomes Short Form-36
Mental and Physical Component Summary
*Higher scores indicate better health-related outcomes (for other measures, higher
scores indicates worse health-related outcomes)496
FACTORS PREDICTING THE EFFICACY OF VISCOSUPPLEMENTATION
IN KNEE OSTEOARTHRITIS
R.M. Koolaee y,z, H. Schumacher, Jr. y,z, M.J. Shoemaker x, S.K. Mooar y,z,
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a. Purpose: Previous research has demonstrated inconsistent effects of
hyaluronic acid supplementation in patients with knee osteoarthritis
(OA), and it is not known which patients will have the best clinical
response to this therapy. The purpose of the present study is to evaluate
some factors that may predict clinical response to a single intra-artic-
ular injection of viscosupplementation with Hylan GF-20.
b. Methods: This is an observational pilot study of 100 patients at
a large urban Veterans Affairs Medical Center (VAMC) with knee oste-
oarthritis who are scheduled to receive viscosupplementation with
Hylan G-F 20 at either the rheumatology or orthopedics clinics. These
patients meet the VAMC formulary guidelines for use of viscosupple-
mentation, which entails failure or intolerance of usual methods for
managing a symptomatic knee, including corticosteroid injections.
Patients with a history of inﬂammatory arthritis (i.e., rheumatoid
arthritis, gout, or pseudogout) are excluded. At baseline, patients
complete a series of questionnaires to obtain the Knee Injury and
Osteoarthritis Outcome Score (KOOS), Patient Health Questionnaire
(PHQ-9) depression score, the New Zealand Joint Priority score (NZ
score), as well as further history concerning demographics and previousinjury, surgery, or other treatment. The KOOS and PHQ-9 are repeated at
3 and 6 months post-injection. A clinical responder is deﬁned as
someone with a change in KOOS total or any one subscale score that
exceeds the mean minimal detectable change (MDC) values calculated
based on test-retest reliability coefﬁcients reported in four prior studies.
Statistical analyses include logistic regression to determine which
clinical variables predict response to therapy, as well as t-tests and chi
square to examine differences in clinical characteristics between
“responders” and “non-responders.” Hypothesized predictors of clinical
response included bodymass index (BMI), NZ Score, age, Kellgren score,
and PHQ-9 score.
c. Results: Preliminary analyses are completed for the 29 subjects who
have completed the 3 month follow-up measures for this ongoing
study. There are 16 responders and 13 non-responders. The method for
determining therapeutic response is effective as evidenced by statisti-
cally signiﬁcant differences between responders and non-responders
for the total and all subscale KOOS scores (p < .05) except for the Sport/
Recreation subscale. Small sample size precluded multivariate logistic
regression. Bivariate analysis revealed no statistically signiﬁcant
differences between responders and non-responders for age, BMI,
Kellgren Score, NZ Score, PHQ-9, and baseline visual analogue scale pain
rating. However, there is a signiﬁcant effect of previous narcotic use on
treatment response (X2¼12.593, p¼.001) with 94% of responders
having no history of narcotic use compared to only 31% of non-
responders who had no narcotic use.
d. Conclusions: The hypothesized factors, to date, have not been useful
to predict response but previous narcotic use has been a strong
predictor of non-response. Small effect sizes of some potential predictor
variables and the small sample size in this preliminary analysis may
explain the lack of other statistically signiﬁcant predictors. By study
completion, it is anticipated that the sample size will provide adequate
statistical power to perform multivariate analysis and determine
whether there are indeed multiple predictors of response to viscosup-
plementation.
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PRE-SURGICAL MANAGEMENT STRATEGIES IN PATIENTS WITH
OSTEOARTHRITIS: A QUALITATIVE STUDY
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Ctr., Toronto, ON, Canada; { St. Michael's Hosp., Toronto, ON, Canada;
# Toronto Western Res. Inst., Toronto, ON, Canada
Purpose: There is a current movement in health care towards self-
management of chronic illness. Arthritis, speciﬁcally osteoarthritis (OA),
is one of the most prominent, disabling and costly chronic diseases. A
recent review of self-management for rheumatic diseases found that
there were modest improvements in the pain, self-efﬁcacy, function
and mood of patients who took part in self-management interventions.
The authors recommended that longer-term beneﬁts of self-manage-
ment programs be investigated, including increased use of qualitative
methods. The overall aim of our study was to qualitatively explore the
experiences of individuals with hip or knee OA at three time points:
prior to joint replacement, 8 months post-surgery and 18 months post-
surgery. This work focuses on participants’ experiences related to the
self-management of their disease prior to surgery.
Methods: 35 participants were recruited from the practices of two
orthopaedic surgeons using ﬁrst a maximum variation and then
a theoretical sampling approach based on age, sex and joint replaced
(hip or knee). This approach is purposive and requires that enough data
are generated to sufﬁciently explore the issues under investigation.
Saturation is reached when no new information or themes are being
generated, at which point interviewing stops. A constructivist grounded
theory design was utilized through in-depth interviewing. Responses
were coded and categorized for simultaneous analysis. An audit trail
was maintained to ensure the trustworthiness of the analysis.
Summaries were written after each interview and memos were created
after each research team meeting. Analysis was reﬂexive and the
research team considered how our own biases might impact our
interpretation of the data.
Results: Patients described adopting awide range of complex strategies
to manage their pain including the use of medications, physiotherapy,
alternative treatments and everyday modiﬁcations to such ordinary
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S259activities as putting on their clothes. In addition, individuals with
multiple co-morbidities had even more complex and challenging self-
management experiences, which resulted in family and friends taking
on additional “work” to compensate. The multi-joint nature of OA and
other co-morbidities further complicated self-management. Many
participants described experiencing pain or stiffness in multiple joints
at the same time as a result of OA. Additionally, several participants had
other health conditions that affected their ability to participate in self-
management activities.
Conclusions: These ﬁndings suggest that previous research on OA self-
management overlooks the everyday modiﬁcations patients already
make to manage their disease prior to surgery, and additionally focuses
solely on the individual patient, ignoring the social context of their lives.
We found that self-management is not an individual activity but rather
can involve the individual's spouse, children, friends and/or co-workers.
Further, self-management is complicated by the multi-joint nature of
OA and by comorbidities. Future approaches to self-management in OA
need to consider these additional issues/aspects as well as the various
psychosocial factors that may inﬂuence patients’ experiences.
498
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TRIALS INVESTIGATING THE EFFECTIVENESS OF INTRA-ARTICULAR
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Purpose: Based on small to moderate effectiveness of the wide range of
symptomatic treatments in osteoarthritis (OA), and the heterogeneity of
OA patients, treatment guidelines for OA have stressed the need for
research on clinical predictors of response to different treatments. A
meta-analysis for quantifying interaction effects using Individual
Patient Data (IPD) is considered to be the gold standard for subgroup
analysis. An initiative to collect and analyse IPD in OA research is
commenced by the ‘OATrial Bank’. The general purpose of this initiative
is to reach consensus on the rules for cooperation in a consortium and
to develop and explore the methodological issues of meta-analysis with
individual OA patient data. The ﬁrst meta-analysis will evaluate the
efﬁcacy of intra-articular (IA) corticosteroids for knee or hip OA in
speciﬁc subgroups of patients with severe pain and (mild) inﬂamma-
tory signs, over both short and long term follow-up, using IPD from
existing trials.
Methods: The OA Trial Bank is set-up as a worldwide collaboration
that initiates meta-analyses on predeﬁned subgroups of OA patients
using data from existing studies. An executive coordinator will
approach internationally acknowledged clinical and epidemiological
researchers in the OA ﬁeld to formalize the steering committee. The
committee will agree on the organisational structure and tasks of all
parties involved, agree on the design and methods of meta-analyses,
the deﬁnition of subgroups and statistical analyses. A licence agree-
ment will be developed to guarantee legal issues between the OA Trial
Bank and data-deliverers. For the ﬁrst IPD analysis, randomised
controlled trials (RCTs) evaluating one or more IA corticosteroid
preparations in patients with OA of the knee or hip, published from
1995 up to June 2012, will be selected from the existing literature.
Corresponding authors of eligible trials will be approached and asked
to cooperate in this project. All data-deliverers will be asked to sign
the licence agreement before the data is transferred to the OA Trial
Bank. Data obtained from the original databases include patient-,
disease- and study characteristics and outcome measures. To assess
potential subgroup effects, a ﬁxed-effects linear regression model will
be used to calculate interaction effects.
Results: A chairman, steering committee and an executive coordinator
formalize the OA Trial Bank (Figure 1). The steering committee guar-
antees continuity of the OA Trial Bank and supervises the executive
coordinator. The committee has approved and agreed the organisa-
tional structure and the tasks of the parties involved (Figure 1). The
content of the licence agreement was provided by the committee,
including data access, transfer and storage, predeﬁned analyses, conﬁ-
dentiality and reliability statement, authorship. A total of 44publications were selected as ‘potentially eligible’. Authors have been
contacted with a data-delivery request.
Conclusions: The international character of the steering committee, the
multidisciplinary structure, the patient involvement and the endorse-
ment of the OARSI and EULAR will all strengthen this initiative and
inspire trialists, i.e. data-deliverers, to join this initiative.
Figure 1. ﬂow chart of organization OA Trial Bank.Ă
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Purpose: Many people suffer from musculoskeletal (MSK) pain. This
pain often has no medical explanation and does not go away. Some
people ﬁnd it so devastating that at times they would rather die than go
on in pain. A greater understanding of patients’ experiences of pain
could have an impact on healthcare in this group. Qualitative research
aims to understand experience, but the increasing number of qualita-
tive studies can make it difﬁcult to use this knowledge to inform clinical
practice. A synthesis of qualitative research would help us to under-
stand what it is like to have chronic MSK pain. Speciﬁcally, it would help
us understand peoples’ experience of healthcare with the aim of
improving it. The aim of this study is to: increase our understanding of
patients’ experiences of chronic MSK pain; utilise existing research
knowledge to improve understanding; and contribute to the develop-
ment of methods for qualitative research synthesis.
Methods: We used the methods of meta-ethnography developed by
Noblit and Hare, which aim to develop concepts that help us to
understand a particular experience, by synthesising research ﬁndings.
We searched six electronic bibliographic databases, and included
studies up until the ﬁnal search in February 2012. We also hand
searched particular journals known to report qualitative studies, and
looked through reference lists. We appraised each study to decide
whether or not to include it. We included 77 qualitative studies that
explored adults’ experience of chronic non-malignant musculoskeletal
(MSK) pain. Twenty eight of these studies explored the experience of
Fibromyalgia.
Results: Our model reveals the concept of an adversarial struggle to
explain the experience of chronic MSK pain. We describe a struggle to
afﬁrm self and explain suffering. Although alienated from the
biomedical model, the person feels compelled to re-enter the health-
care system in order to establish legitimacy. Despite a fundamental
need to feel that the health professional is alongside them, people with
chronic pain do not feel believed or valued. Chronic pain is experienced
as non-legitimate, and the person uses strategies to gain legitimacy; for
